Oncology at Children's National - Children's National

Home to one of the nation's leading pediatric oncology programs, the Cancer and Blood Disorders Center at Children's National provides unparalleled expertise in diagnosing and treating the most complex childhood cancers and blood disorders, from infancy through young adulthood. Supported by the Children's National Research Institute, our physician-scientists are advancing breakthroughs in targeted therapies, precision medicine and immunotherapy. Through leadership in clinical trials, genomic profiling, advanced imaging and cellular therapies, Children's National continues to set the standard for excellence in pediatric cancer care and survivorship.

Nationally ranked pediatric oncology program, recognized among the nation's best by U.S. News & World Report.

We received more than $26 million in funding from the NIH last year, driving innovations that improve outcomes for children with cancer and blood disorders.

The region's only pediatric hospital with specialized cancer and stem cell transplant programs, providing nationally recognized expertise in advanced pediatric transplant care.

Delivered the world's first pediatric gene therapy for sickle cell disease in 2024, using a patient's own genetically modified stem cells to dramatically reduce or potentially eliminate painful sickle cell crises.

Pioneered a first-of-its-kind Sickle Cell Integrative Health Program designed to enhance quality of life for patients and families, bringing together specialized care and support to improve quality of life for patients and families.

The region's only program offering dedicated, disease-specific care teams, giving children and families access to specialized expertise for every major type of childhood cancer and blood disorder.

Our comprehensive cancer programs care for more children each year than all other hospitals in the metro area combined, bringing unmatched depth of experience to every diagnosis.